Humana Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Humana de 14.7% y 4.6% por año respectivamente. Se prevé que el BPA crezca en un 17.6% al año. Se espera que la rentabilidad financiera sea de 15.5% en 3 años.

Información clave

14.4%

Tasa de crecimiento de los beneficios

17.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	16.0%
Tasa de crecimiento de los ingresos	4.6%
Rentabilidad financiera futura	15.4%
Cobertura de analistas	Good
Última actualización	25 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Humana Inc.'s (NYSE:HUM) Intrinsic Value Is Potentially 92% Above Its Share Price

Sep 21

Humana adds 9%, highest in over two years, after lifting guidance

Sep 15

Humana: Time To Adopt A More Defensive Portfolio Strategy

Sep 04

Humana declares $0.7875 dividend

Aug 18

Humana to acquire Wisconsin managed care organization Inclusa

Aug 12

Previsiones de crecimiento de beneficios e ingresos

NYSE:HUM - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	121,710	2,823	3,660	4,426	12
12/31/2025	116,103	2,326	3,139	3,762	16
12/31/2024	113,937	1,794	1,927	2,420	14
3/31/2024	109,243	1,991	-3,241	-2,283	N/A
12/31/2023	106,374	2,489	2,977	3,981	N/A
9/30/2023	102,351	3,015	5,009	5,988	N/A
6/30/2023	98,727	3,378	12,156	13,189	N/A
3/31/2023	95,642	3,115	9,907	10,972	N/A
12/31/2022	92,870	2,806	3,450	4,587	N/A
9/30/2022	91,485	2,807	8,385	9,618	N/A
6/30/2022	90,512	3,143	2,729	4,000	N/A
3/31/2022	87,495	3,035	2,080	3,401	N/A
12/31/2021	83,064	2,933	920	2,262	N/A
9/30/2021	82,201	2,673	1,400	2,641	N/A
6/30/2021	80,450	2,482	456	1,621	N/A
3/31/2021	78,888	3,722	3,266	4,328	N/A
12/31/2020	77,155	3,367	4,675	5,639	N/A
9/30/2020	74,388	4,153	4,970	5,868	N/A
6/30/2020	70,554	3,502	5,637	6,495	N/A
3/31/2020	67,716	2,614	4,073	4,862	N/A
12/31/2019	64,888	2,707	4,548	5,284	N/A
9/30/2019	62,761	2,550	3,757	4,439	N/A
6/30/2019	60,726	2,505	306	942	N/A
3/31/2019	58,740	1,758	-1,234	-617	N/A
12/31/2018	56,912	1,683	1,561	2,173	N/A
9/30/2018	55,933	1,512	-989	-405	N/A
6/30/2018	55,009	1,367	2,950	3,513	N/A
3/31/2018	54,284	1,824	2,996	3,532	N/A
12/31/2017	53,767	2,448	N/A	4,051	N/A
9/30/2017	53,456	1,863	N/A	4,189	N/A
6/30/2017	53,868	1,814	N/A	5,829	N/A
3/31/2017	54,341	1,475	N/A	5,639	N/A
12/31/2016	54,379	614	N/A	1,936	N/A
9/30/2016	54,862	1,116	N/A	5,046	N/A
6/30/2016	54,531	980	N/A	1,575	N/A
3/31/2016	54,256	1,100	N/A	1,263	N/A
12/31/2015	54,289	1,276	N/A	868	N/A
9/30/2015	53,256	1,320	N/A	724	N/A
6/30/2015	52,131	1,296	N/A	646	N/A
3/31/2015	50,621	1,209	N/A	1,054	N/A
12/31/2014	48,500	1,147	N/A	1,618	N/A
9/30/2014	46,359	972	N/A	1,409	N/A
6/30/2014	44,440	1,050	N/A	1,602	N/A
3/31/2014	42,539	1,126	N/A	1,975	N/A
12/31/2013	41,313	1,231	N/A	1,716	N/A
9/30/2013	40,683	1,453	N/A	1,937	N/A
6/30/2013	40,015	1,511	N/A	-544	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14.7% al año) de HUM es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (14.4% al año) de HUM crezcan menos que el mercado US (14.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de HUM crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (4.6% al año) de HUM crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4.6% al año) de HUM crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de HUM sea baja dentro de 3 años (15.5%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Humana Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. Provides Earnings Guidance for 2024

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Price target increased to US$603

Consensus forecasts updated

Recent updates

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Dividend of US$0.89 announced

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana: Where To Buy This

Humana: This Year's Drop Might Have Created A Buying Opportunity

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Humana Inc. Provides Earnings Guidance for 2024

Humana: The $300 Level Could Get Taken Out In The Near Future

Humana Announces Limited Layoffs

Humana: My Oh My, Another Strong Buy

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Upcoming dividend of US$0.89 per share at 0.8% yield

President exercised options and sold US$1.3m worth of stock

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana: Upgrade To Buy

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana: Mr. Market Got This One Right

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana: Recent Selloff Might Present A Buying Opportunity

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Humana: Rising Medical Costs Should Be Temporary

Upcoming dividend of US$0.89 per share at 0.8% yield

Humana: Margin Expansion Supported By Growing Memberships

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

First quarter 2023 earnings: Revenues exceed analyst expectations

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

President notifies of intention to sell stock

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Full year 2022 earnings: EPS misses analyst expectations

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Q4 2022 Earnings Preview

Humana: Destined For A Long-Term Success

Humana (NYSE:HUM) Could Easily Take On More Debt

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Independent Director recently sold US$7.5m worth of stock

Humana receives $70.85B contract from Defense Health Agency

President exercised options and sold US$1.5m worth of stock

Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

President recently sold US$3.7m worth of stock

Price target increased to US$603

Humana: Top-Rated Medicare Advantage Insurer With Room To Grow

Consensus forecasts updated

Segment President of Retail recently sold US$4.0m worth of stock

Humana prices $1.23B debt offering

Segment President of Retail notifies of intention to sell stock